| Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ... The Lancet 379 (9829), 1879-1886, 2012 | 2479 | 2012 |
| Pathology and genetics of tumours of soft tissue and bone CDM Fletcher, KK Unni, F Mertens Iarc, 2002 | 2101 | 2002 |
| Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial I Judson, J Verweij, H Gelderblom, JT Hartmann, P Schöffski, JY Blay, ... The lancet oncology 15 (4), 415-423, 2014 | 1228 | 2014 |
| Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts H Joensuu, A Vehtari, J Riihimäki, T Nishida, SE Steigen, P Brabec, ... The lancet oncology 13 (3), 265-274, 2012 | 1186 | 2012 |
| The 2020 WHO classification of soft tissue tumours: news and perspectives M Sbaraglia, E Bellan, AP Dei Tos Pathologica 113 (2), 70, 2020 | 1136 | 2020 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of Oncology 29, iv51-iv67, 2018 | 1090 | 2018 |
| Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ESMO/European Sarcoma Network Working Group Annals of Oncology 25, iii21-iii26, 2014 | 1063* | 2014 |
| Whole-genome landscape of pancreatic neuroendocrine tumours A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ... Nature 543 (7643), 65-71, 2017 | 1062 | 2017 |
| Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ESMO/European Sarcoma Network Working Group Annals of Oncology 25, iii102-iii112, 2014 | 1062* | 2014 |
| Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, N Abecassis, S Bauer, R Biagini, S Bielack, S Bonvalot, ... Annals of oncology 29, iv68-iv78, 2018 | 1058* | 2018 |
| Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO JY Blay, S Bonvalot, P Casali, H Choi, M Debiec-Richter, AP Dei Tos, ... Annals of Oncology 16 (4), 566-578, 2005 | 1036 | 2005 |
| Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ A Gronchi, AB Miah, AP Dei Tos, N Abecassis, J Bajpai, S Bauer, ... Annals of Oncology 32 (11), 1348-1365, 2021 | 989 | 2021 |
| Rare cancers are not so rare: the rare cancer burden in Europe G Gatta, JM Van Der Zwan, PG Casali, S Siesling, AP Dei Tos, I Kunkler, ... European journal of cancer 47 (17), 2493-2511, 2011 | 964 | 2011 |
| Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, S Bielack, N Abecassis, HT Aro, S Bauer, R Biagini, ... Annals of Oncology 29, iv79-iv95, 2018 | 668 | 2018 |
| Twist is a potential oncogene that inhibits apoptosis R Maestro, AP Dei Tos, Y Hamamori, S Krasnokutsky, V Sartorelli, ... Genes & development 13 (17), 2207-2217, 1999 | 657 | 1999 |
| Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study G Gatta, L Botta, MJ Sánchez, LA Anderson, D Pierannunzio, L Licitra, ... European journal of cancer 51 (15), 2130-2143, 2015 | 627 | 2015 |
| Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up PG Casali, JY Blay, N Abecassis, J Bajpai, S Bauer, R Biagini, S Bielack, ... Annals of oncology 33 (1), 20-33, 2022 | 559 | 2022 |
| Calretinin: a novel immunocytochemical marker for mesothelioma C Doglioni, AP Dei, L Laurino, P Iuzzolino, C Chiarelli, MR Celio, G Viale The American journal of surgical pathology 20 (9), 1037-1046, 1996 | 556 | 1996 |
| Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label … A Gronchi, S Ferrari, V Quagliuolo, JM Broto, AL Pousa, G Grignani, ... The Lancet Oncology 18 (6), 812-822, 2017 | 548 | 2017 |
| Liposarcoma: new entities and evolving concepts AP Dei Tos Annals of diagnostic pathology 4 (4), 252-266, 2000 | 505 | 2000 |
Maestro RobertaDirector, Unit of Experimental Oncology 1, CRO Aviano National Cancer Institute (Italy)Verified email at cro.it
